Drug Name:
VITAFOL-OB Rx
Generic Name and Formulations:
Vit.A (as beta carotene) 2700 IU, thiamine 1.6mg, riboflavin 1.8mg, niacinamide 18mg, pyridoxine 2.5mg, folic acid 1mg, Vit.B12 12mcg, Vit.C 70mg, Vit.D 400 IU, Vit.E 30 IU, calcium (as carbonate) 100mg, copper (as oxide) 2mg, iron (as ferrous fumarate) 65mg, magnesium (as oxide) 25mg, zinc (as oxide) 25mg; caplets; gluten-, lactose-, iodine-, sugar-free.
Company:
Exeltis USA
Therapeutic Use:
Indications for VITAFOL-OB:
Nutritional supplement in pregnancy, prenatal, and postnatal periods.
Adult:
1 cap daily.
Children:
Not recommended.
Contraindications:
Pernicious anemia. Hemochromatosis. Iron storage disease. Chronic hemolytic anemia. Pyridoxine responsive anemia. Liver cirrhosis.
Warnings/Precautions:
Folic acid may mask pernicious anemia. Overactive thyroid. Hypercalcemia. Hyperparathyroidism. Soy allergy. DHA: bleeding diatheses.
Interactions:
Iron, calcium block tetracycline absorption. Iodine with anti-thyroid drugs may cause hypothyroidism. Iodine with antihypertensives may increase potassium. Folic acid antagonizes methotrexate, anticonvulsants (eg, carbamazepine, fosphenytoin, phenytoin, phenobarbital, valproic acid). Separate dosing of zinc with antibiotics at least 2hrs apart. DHA: avoid anticoagulants.
See Also:
Adverse Reactions:
GI upset, skin ailments, glucose abnormalities, visual problems.
How Supplied:
Caplets—100; Softgel caps—30;
DHA (6 blister cards [5 caplets + 5 gel caps])—30-day supply
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments